Lehigh Valley Health Network Selects StudyManager Reveal for Clinical Trial Management
StudyManager announced that Lehigh Valley Health Network selected StudyManager’s Reveal software to manage its clinical trials.
As a health network that includes three hospital facilities, nine health centers, and numerous primary and specialty care physician practices located throughout the state of Pennsylvania, Lehigh Valley Health Network sought a solution to centralize activity across multiple facilities and departments. Billing and protocol compliance, financial accountability, patient tracking, and high-level reporting for management oversight were all important criteria in selecting a CTMS system. Following an in-depth review process, Lehigh Valley selected StudyManager Reveal.
“We sought a CTMS that would centralize and organize our research operations to replace numerous manual and fragmented methods of capturing and recording data across our many research departments,” said Eric Mueller, MSA, Director of Research Administration, Lehigh Valley Health Network. “After evaluating several CTMS systems, we felt that StudyManager Reveal provided us the standardization needed, as well as the reporting capabilities to meet our compliance, study and patient tracking, and financial requirements.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
